Shares of Medexus Pharmaceuticals Inc. (TSE:MDP – Get Free Report) fell 2.4% during mid-day trading on Tuesday . The company traded as low as C$4.79 and last traded at C$4.84. Approximately 69,983 shares traded hands during mid-day trading, an increase of 46% from the average daily volume of 47,993 shares. The stock had previously closed at C$4.96.
Medexus Pharmaceuticals Trading Down 2.4%
The stock has a market capitalization of C$153.23 million, a price-to-earnings ratio of -69.14 and a beta of 0.22. The firm has a 50-day moving average of C$4.47 and a 200 day moving average of C$3.70.
Medexus Pharmaceuticals Company Profile
Medexus is a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative and rare disease treatment solutions. Medexus’s current focus is on the therapeutic areas of hematology and hematology-oncology and rheumatology and allergy.
Further Reading
- Five stocks we like better than Medexus Pharmaceuticals
- These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
- Hasbro’s Earnings Beat Shows Why This Is No Longer Just a Toy Story
- Rambus: Another AI Phoenix Ready to Rise From the Ashes of Correction
- Chips & Clips: Memory Tariffs Rewire Tech Supply Chains
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
